Phase 3 N=142 Uric Acid and Hypertension in African Americans
Cardiovascular Diseases · Heart Diseases · Hypertension
Primary: Change in Diastolic Blood Pressure by Cuff 8-10 Weeks Minus Baseline — 3.44; -0.83 mm Hg — p=0.059
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=72 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Diabetic Macular Edema
Primary: Proportion of Subjects Who Gain Two or More Lines in Best Corrected Visual Acuity(BCVA) Score in the Study Eye Compared With Baseline. — 3; 18 participants
Phase 2 N=41 S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Prostate Cancer
Primary: Progression-free Survival — 13 months
N/A N=40 Comparative Study of Sham Versus Mild® Procedure in Patients Diagnosed With Symptomatic Lumbar Central Canal Stenosis
Lumbar Spine Stenosis Central Canal
Primary: Visual Analog Scale (VAS) <=4 — 11; 2 participants
Phase 1 N=26 Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted Conditions
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 265.96; 260.04 ng/ml
Phase 4 N=162 A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy
Diabetic Neuropathy
Primary: Change From Baseline in Pain Intensity Score at Day 43 — 6.65; 6.30; 3.15; 2.76 Units on a scale — p=0.2143
Phase 2 N=19 Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
Subarachnoid Hemorrhage
Primary: Mean Plasma Nitrite Concentration (Micromol/L) — 4.2; 4.3; 2.6 micromol/L
Phase 4 N=42 Evaluate Recovery of Testosterone for Patients Using Eligard
Prostate Cancer
Primary: Serum Testosterone Recovery — 6 Months
Phase 2 N=21 Occlusal Adjustment as Treatment for Chronic Orofacial Pain
Temporomandibular Joint Disorders · Orofacial Pain
Primary: Visual Analogic Scale for Pain Intensity (0-10) — 6.52; 4.8; .81; 2.05 units on a scale
Phase 3 N=202 Imatinib (QTI571) in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Primary: Difference in Six-minute Walk Distance Test (6MWD) Between Imatinib and Placebo at 24 Weeks — 382.94; 351.18 meters
Phase 2 N=60 Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Pancreatic Cancer
Primary: Overall Survival — 24.8 Months
Phase 4 N=270 Trichomonas Vaginalis Recurrence Among HIV+ Women
Trichomonas Infections · HIV Infections
Primary: TV Culture Positive Result — 11; 21 participants — p=.045
Phase 3 N=84 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Short Bowel Syndrome
Primary: A Graded Response Score in Parenteral Nutrition (PN) Reduction — 15; 19; 24; 0 participants — p=0.007
Phase 2 N=71 Auriculotherapy Effectiveness on Stress and Anxiety in Nursing Student
Stress · Anxiety
Primary: Students Stress Levels — 75.62; 67.72; 72.45 units on a scale — p=0.006
Phase 3 N=243 A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Macular Edema · Diabetic Mellitus · Retinal Disease
Primary: Number of Participants Who Experience a ≥10 Letter Improvement of Visual Acuity (VA) in Early Treatment Diabetic Retinopathy Study (ETDRS) Chart From Baseline at Week…